Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Atara Biotherapeutics Inc

TRADE

NASDAQ: ATRAHealthcare / Biotechnology / USA
39.30-0.55-1.38%Vol 291 4521Y Perf 146.39%
Jul 19th, 2018 16:00
BID35.00 ASK39.40
Open39.60 Previous Close39.85
Pre-Market- After-Trading39.30
 - -%  - -%
Target Price
50.00 
Analyst Rating
Moderate Buy 2.14
Potencial %
27.23 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-100/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-100/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-100/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 727 
Earnings Rating
Sell
Price Range Ratio 52wk %
63.76 
Earnings Date
6th Aug 2018

Today's Price Range

39.0540.00

 

52wk Range

12.6554.45

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-16.20%
3 Months
-0.51%
6 Months
33.22%
1 Year
146.39%
3 Years
-30.20%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ATRA39.30-0.5500-1.38
AAPL191.881.48000.78
GOOG1 186.96-8.9200-0.75
MSFT104.40-0.7200-0.68
XOM82.01-0.2100-0.26
WFC56.33-0.2400-0.42
JNJ125.94-1.8600-1.46
FB208.09-1.2700-0.61
GE13.73-0.0200-0.15
JPM109.89-1.6400-1.47
...

TickerPriceChg.%52 Week High
SNA173.299.50185.47
DOV78.125.3088.11
DHR103.204.47106.08
SCG40.203.5368.35
SWN5.363.476.72
WMB28.693.3533.67
M38.963.3441.33
SIG60.663.3277.94
IBM149.243.27171.13
AZO716.173.19797.89
PDCO22.983.1443.20
ORLY299.233.00300.07
D72.002.9385.30
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 19.40
Current Ratio 19.70
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.00
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -15.20
Cash Flow Per Share -3.09
Price to Tangible Book4.00
Book Value per Share9.99
Enterprise Value (in ths.)1 348 460
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-37.71
ROE last 12 Months -38.16
Return on Assets (5Y Avg) -16.83
ROA last 12 Months -35.94
Return on Capital (5Y Avg) -
ROC last 12 Months -40.24
Return on invested Capital Q -13.43
Return on invested Capital Y-55.37
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.93-1.05-12.90
Q04 2017-1.15-1.150.00
Q03 2017-1.03-1.020.97
Q02 2017-0.91-0.94-3.30
Q01 2017-0.77-0.88-14.29
Q04 2016-0.91-0.6330.77
Q03 2016-0.79-0.88-11.39
Q02 2016-0.62-0.66-6.45
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.97-5.43Negative
9/2018 QR-1.00-6.38Negative
12/2018 FY-4.06-7.69Negative
12/2019 FY-4.34-9.05Negative
Next Report Date6th Aug 2018
Estimated EPS Next Report-0.97
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume291 452
Shares Outstanding (in ths.)43 950
Trades Count1 454
Dollar Volume10 337 815
Avg. Volume785 547
Avg. Weekly Volume299 335
Avg. Monthly Volume541 009
Avg. Quarterly Volume553 660

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

64%36%

Bearish Bullish

63%37%

Bearish Bullish

56%44%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (57.14 %)
4 (57.14 %)
4 (57.14 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (28.57 %)
2 (28.57 %)
2 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (14.29 %)
1 (14.29 %)
1 (14.29 %)
RatingModerate Buy
2.14
Moderate Buy
2.14
Moderate Buy
2.14

There are no comments yet.

News

x